BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore

Medidata eCOA Named Highest Leader in Everest Group’s 2025 Life Sciences PEAK Matrix® Assessment

Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to ...

September 05, 2025 | News

HEC Group and JungKwanJang Forge Strategic Alliance to Elevate Global Health Industry

The JungKwanJang delegation included Kim Yang-jin, Director General of the Overseas Business Division; Jung Jong, Director General of the As...

September 01, 2025 | News

Cambridge CARES And A*STAR Develop AI-Powered Digital Twin Platform For Pharmaceutical Manufacturing

Cambridge Advanced Research and Education in Singapore (CARES), the University of Cambridge's first overseas research centre, togethe...

August 28, 2025 | News

Mitsubishi Corporation Acquires Strategic Minority Stake In Fullerton Health To Drive Regional Growth

Fullerton Health Pte. Ltd. ("Fullerton Health" or the "Company"), a leading healthcare solutions provider operating in nine markets across Asia-Pacifi...

August 27, 2025 | News

Asia Bio Innovation Summit 2025 Highlights ADC and CGT as Dual Engines of Biopharma Innovation

Asia Bio Innovation Summit 2025 is one of the premier industry-focused events in Asia and focus on the hottest topics of ADC and CGT. Asia B...

August 25, 2025 | News

Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025

The first eight months of 2025 have been transformative for biosupplier technologies worldwide. From innovative lab reagents and biomaterials to ad...

August 22, 2025 | Analysis

Spring Bio Solution to Launch LSPedia’s OneScan in India, Europe, and Singapore for Next-Generation Pharma Compliance

LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, today announced a strategic partnership with ...

August 21, 2025 | News

Sanofi and AstraZeneca’s Beyfortus Receives HSA Approval to Prevent RSV in Infants

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety ...

August 20, 2025 | Regulatory

KBP Biosciences Welcomes Court’s Decision to Maintain Injunction Pending Arbitration with Novo Nordisk

KBP Biosciences Pte. Ltd. issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the te...

August 13, 2025 | Regulatory

GenScript Launches ‘Scripting Possibilities’—A Bold Global Brand Identity to Power the Future of Life Sciences

GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, unveiled its new global brand platform: Scripting Possibilities...

August 11, 2025 | News

Nebius Is Accelerating Drug Discovery with AI Infrastructure That Slashes Timelines from Years to Months

The traditional 7–10-year timeline for drug discovery is rapidly becoming obsolete. Thanks to advances in AI and compute infrastructure, pioneers lik...

August 04, 2025 | Interview

WuXi Biologics Begins Construction of One of the World’s Largest Modular Biologics Drug Product Facilities in Singapore

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse ...

July 30, 2025 | News

Agilent Deepens Partnership with NTU Singapore’s NEWRI to Advance Water Sustainability

-Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with the Nanyang Environment & Water...

July 29, 2025 | News

Shanton Pharma’s SAP-001 Receives FDA Fast Track Designation for Refractory Gout Treatment

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, announced that FDA has designated its Investigational New Dru...

July 28, 2025 | News

Stay Connected